Quick Answer
Prime Medicine, Inc. reported Total Assets of $342.73 million for the year ending 2025.
- Prime Medicine, Inc. showed an increase of +15.2% in Total Assets from 2024 to 2025.
- This data is from Prime Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $215.27 million | Q1 2023: $316.95 million | Q2 2023: $280.87 million | Q3 2023: $239.15 million | Q1 2024: $311.38 million | Q2 2024: $259.71 million | Q3 2024: $332.78 million | Q1 2025: $328.16 million | Q2 2025: $279.01 million | Q3 2025: $385.01 million.
- Over the full 5 years of available data (2021 to 2025), Prime Medicine, Inc.'s Total Assets has grown by 13.5%.
- Historical annual values: Fiscal year 2025: $342.73 million | Fiscal year 2024: $297.51 million | Fiscal year 2023: $193.85 million | Fiscal year 2022: $360.31 million | Fiscal year 2021: $301.86 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: